Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_assertion type Assertion NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_head.
- NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_assertion description "[Patients with high MBL2 promoter genotypes and haplotypes seem more at risk for developing febrile neutropenia. If confirmed, these preliminary findings may contribute to more individualized approaches of irinotecan treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_provenance.
- NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_assertion evidence source_evidence_literature NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_provenance.
- NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_assertion SIO_000772 20930093 NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_provenance.
- NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_assertion wasDerivedFrom gad-20150221 NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_provenance.
- NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_assertion wasGeneratedBy ECO_0000203 NP187025.RAAyd5exPuxuTKNAHjCVFGiej-yv5kOe4yLK5r6_FVHBk130_provenance.